Green Thumb Industries (GTBIF) Operating Leases (2019 - 2026)
Green Thumb Industries (GTBIF) posted Operating Leases of $253.5 million for Q1 2026, down 0.64% on a QoQ basis from $255.1 million in Q4 2025, and down 1.96% year-over-year from $258.5 million in Q1 2025.
Green Thumb Industries (GTBIF) Operating Leases (2019 - 2026) Analysis & Trends
Green Thumb Industries' Operating Leases history runs 8 years deep, the most recent figure standing at $253.5 million for Q1 2026.
- Quarterly Operating Leases fell 1.96% year-over-year to $253.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $253.5 million (down 1.96% YoY) and the FY2025 annual result came in at $255.1 million, down 2.43% from the prior year.
- Operating Leases was $253.5 million for Q1 2026 at Green Thumb Industries, down from $255.1 million in the prior quarter.
- Across five years, Operating Leases topped out at $261.4 million in Q4 2024 and bottomed at $186.1 million in Q1 2022.
- A 5-year average of $249.9 million and a median of $253.2 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases jumped 50.53% — and 2025, when it decreased 2.64%.
- Green Thumb Industries' Operating Leases stood at $249.3 million in 2022, then rose by 0.07% to $249.5 million in 2023, then advanced by 4.8% to $261.4 million in 2024, then decreased by 2.43% to $255.1 million in 2025, then retreated by 0.64% to $253.5 million in 2026.
- Business Quant data shows GTBIF's Operating Leases at $253.5 million in Q1 2026, $255.1 million in Q4 2025, and $253.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253.46 Mn |
| Dec 31, 2025 | 255.10 Mn |
| Sep 30, 2025 | 253.92 Mn |
| Jun 30, 2025 | 256.81 Mn |
| Mar 31, 2025 | 258.53 Mn |
| Dec 31, 2024 | 261.45 Mn |
| Sep 30, 2024 | 260.79 Mn |
| Jun 30, 2024 | 261.03 Mn |
| Mar 31, 2024 | 253.22 Mn |
| Dec 31, 2023 | 249.46 Mn |
| Sep 30, 2023 | 250.02 Mn |
| Jun 30, 2023 | 248.33 Mn |
| Mar 31, 2023 | 251.61 Mn |
| Dec 31, 2022 | 249.28 Mn |
| Sep 30, 2022 | 249.45 Mn |
| Jun 30, 2022 | 249.15 Mn |
| Mar 31, 2022 | 186.08 Mn |
| Dec 31, 2021 | 182.54 Mn |
| Sep 30, 2021 | 180.86 Mn |
| Jun 30, 2021 | 165.51 Mn |